Cart
sales@molnova.com
NSC 405020
CAS No. 7497-07-6
NSC 405020( NSC-405020 | NSC 405020 | NSC405020 )
Catalog No. M15856 CAS No. 7497-07-6
NSC 405020 is a noncatalytic inhibitor of MT1-MMP, directly interacts with PEX domain of MT1-MMP, affects PEX homodimerization but not catalytic activity of MT1-MMP.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 5MG | 37 | In Stock |
|
| 10MG | 57 | In Stock |
|
| 25MG | 114 | In Stock |
|
| 100MG | 325 | In Stock |
|
| 200MG | 491 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNSC 405020
-
NoteResearch use only, not for human use.
-
Brief DescriptionNSC 405020 is a noncatalytic inhibitor of MT1-MMP, directly interacts with PEX domain of MT1-MMP, affects PEX homodimerization but not catalytic activity of MT1-MMP.
-
DescriptionNSC 405020 is a noncatalytic inhibitor of MT1-MMP, directly interacts with PEX domain of MT1-MMP, affects PEX homodimerization but not catalytic activity of MT1-MMP.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC-405020 | NSC 405020 | NSC405020
-
PathwayMetabolic Enzyme/Protease
-
TargetMMP
-
RecptorMT1-MMP
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number7497-07-6
-
Formula Weight260.16
-
Molecular FormulaC12H15Cl2NO
-
Purity>98% (HPLC)
-
SolubilityEthanol: 52 mg/mL (199.87 mM); DMSO: 52 mg/mL (199.87 mM)
-
SMILESO=C(NC(C)CCC)C1=CC=C(Cl)C(Cl)=C1
-
Chemical Name3,4-Dichloro-N-(1-methylbutyl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Remacle AG, et al. Y Res. 2012 May 1;72(9):2339-49.
molnova catalog
related products
-
MMP-9-IN-6
MMP-9-IN-6 is an MMP-9 inhibitor with an IC50 value of 50 μM and good anti-ulcer efficacy.MMP-9-IN-6 has potential anti-tumor activity and can be used to study tissue remodeling, wound repair and atherosclerosis.
-
SB-3CT
SB-3CT is an effective and selective gelatinase inhibitor with Ki of 13.9 nM and 600 nM for MMP-2 and MMP-9, respectively.
-
CL-82198
CL-82198 is a selective inhibitor of MMP-13 and it is a pharmacologic treatment for preventing osteoarthritis (OA) progression.
